Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RRX✓SelectedUSD · RRXGSK vs RRX performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs RRX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
RRX return
+158.4%
Excess return
-61.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRRXExcessAlpha
1D-0.1%-7.0%+6.8%+0.7%
7D-5.3%-13.6%+8.3%-3.7%
30D-3.7%-4.0%+0.4%-3.5%
3M-7.3%-7.9%+0.7%-6.8%
6M-4.2%-21.6%+17.4%-2.6%
YTD+0.9%+9.2%-8.3%-2.6%
1Y+7.3%+19.3%-12.0%+2.3%
3Y+52.7%+34.9%+17.8%+38.1%
5Y+40.1%-6.9%+47.0%+32.5%
All+97.1%+158.4%-61.3%+44.3%

Cumulative growth

Daily Returns

Daily percentage return beside RRX.

Daily Out/Under-Performance

Portfolio return minus RRX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RRX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling